Chemoradiotherapy alone or chemoradiotherapy followed by surgery in rectal cancer Fabian LungerGeorgios Peros short review 13 March 2020 Pages: 324 - 328
PARP inhibitors in the treatment of ovarian cancer Alain G. ZeimetVerena WieserChristian Marth review Open access 13 March 2020 Pages: 198 - 201
Obstipation and diarrhoea in palliative care—a pharmacist’s view Marie-Bernadette Aretin short review Open access 13 March 2020 Pages: 44 - 47
The role of surgery in soft tissue sarcoma: Can we improve outcome and function towards sporting activities? Reinhard WindhagerGerhard M. Hobusch short review Open access 09 March 2020 Pages: 164 - 168
Different CALR mutation subtypes in essential thrombocythemia and primary myelofibrosis patients without JAK2 mutation Layla M. SalehReem AlgamalHasan Abdel-ghaffar original report 03 March 2020 Pages: 235 - 243
Young hematologists and medical oncologists in focus Barbara KiesewetterAndreas Pircherthe “Young Hematologists & Oncologists Group Austria” (YHOGA) editorial 03 March 2020 Pages: 9 - 10
End-of-life therapy: palliative care instead of palliative scare Eva Katharina Masel editorial 03 March 2020 Pages: 7 - 8
The golden anniversary of the Austrian Society of Hematology and Medical Oncology (OeGHO) Wolfgang Hilbe editorial 03 March 2020 Pages: 1 - 2
Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology Supplement 2/20 03 March 2020 Pages: 23 - 65
PLATON: use of romiplostim to treat chronic primary immune thrombocytopenia Georgi MihaylovBarbara SkopecPeter Černelč original report Open access 25 February 2020 Pages: 227 - 234
The role of pathology in sarcoma Bernadette Liegl-Atzwanger short review Open access 20 February 2020 Pages: 159 - 163
Ensuring center quality, proper patient selection and fair access to chimeric antigen receptor T-cell therapy: position statement of the Austrian CAR-T Cell Network Hildegard T. GreinixAndishe AttarbaschiUlrich Jaeger special report Open access 20 February 2020 Pages: 27 - 31
Current state and perspectives of checkpoint inhibitors in ovarian cancer treatment Thomas BartlValentina PaspaljChristoph Grimm short review Open access 17 February 2020 Pages: 202 - 206
Molecular profiling in breast cancer—ready for clinical routine? Kristina A. TendlZsuzsanna Bago-Horvath short review Open access 06 February 2020 Pages: 445 - 449
AML—is it time to drive a CAR(-T)? Jakob D. RudzkiDominik Wolf short review Open access 05 February 2020 Pages: 50 - 54
Evidence-based follow-up in patients with Hodgkin’s lymphoma and aggressive B-cell non-Hodgkin’s lymphoma Thomas Spanberger review 04 February 2020 Pages: 55 - 59
A GLOBAL DIGEST ON APPROACHES IN ADVANCED SOLID TUMORS. Report from the ESMO 2019 Congress, Barcelona, September 27th – October 1st 2019 ESMO 2019 04 February 2020 Pages: 1 - 22
Incidental thyroid papillary microcarcinoma on 1777 surgically treated patients for benign thyroid disease Gaia PelusoStefania MasoneMichele L. Santangelo original report Open access 31 January 2020 Pages: 126 - 133
Screening for ovarian cancer: is there still hope? Stefanie AustVeronika Seebacher-Shariat short review Open access 27 January 2020 Pages: 189 - 192
CAR T-cell therapy in diffuse large B-cell lymphoma Georg HopfingerNina Worel short review Open access 24 January 2020 Pages: 32 - 35
The 2020 update of the recommendations of the Austrian working group on lung pathology and oncology for the diagnostic workup of non-small cell lung cancer with focus on predictive biomarkers Helmut H. PopperUlrike Gruber-MösenbacherRichard Wasicky special report 24 January 2020 Pages: 11 - 26
Evidence-based follow-up in lung cancer? Caecilia NgAndreas PircherFlorian Kocher short review Open access 23 January 2020 Pages: 73 - 77
Evidence-based follow-up in non-small cell lung cancer Stefan B. Watzka short review 23 January 2020 Pages: 69 - 72
Palliative sedation for delirium management at the end of life Sophie Roider-Schur short review 20 January 2020 Pages: 93 - 97
The top ten things that must be known about end of life therapy in patients with advanced cancer Gudrun KreyeBettina HeideckerEva K. Masel short review 16 January 2020 Pages: 88 - 92
CAR-T cells in multiple myeloma: current status Normann SteinerEberhard Gunsilius short review Open access 16 January 2020 Pages: 43 - 49
Complete remission of disseminated Langerhans cell sarcoma after stem cell transplantation Verena SchlintlKonstantin SchlickRichard Greil case report Open access 15 January 2020 Pages: 102 - 105
Epidemiology and predictors of survival of tongue cancer among Egyptians in the Delta region Omar HamdyMahmoud M. SalehIslam H. Metwally original report 09 January 2020 Pages: 118 - 125
While I breathe, I hope. Principles of palliative care in chronic breathlessness and advanced lung diseases Eva Katharina Masel short review Open access 09 January 2020 Pages: 98 - 101
Importance of avoiding late cancer-directed therapy in terminally ill cancer patients Daniela Jahn-Kuch short review 09 January 2020 Pages: 84 - 87
Cutaneous squamous cell carcinoma Magdalena Seidl-PhilippVan Anh Nguyen short review Open access 08 January 2020 Pages: 106 - 110
Perioperative treatment of soft-tissue sarcoma Christian Rothermundt short review Open access 07 January 2020 Pages: 174 - 178
Evidence-based follow-up in colorectal cancer—quo vadis? Manuel MaglioneAlexander Perathoner short review Open access 12 December 2019 Pages: 64 - 68
Optimizing care for geriatric cancer patients: the greatest challenge in medical oncology? Rupert Bartsch editorial 09 December 2019 Pages: 288 - 289
Amazing advances in the field of uro-oncology Dora Niedersüß-Beke editorial 09 December 2019 Pages: 286 - 287
An update from the 2019 ASCO Annual Meeting Rupert Bartsch editorial 09 December 2019 Pages: 285 - 285
Biomarkers in renal cell carcinoma Jasmin TerzicThomas Bauernhofer short review 28 November 2019 Pages: 342 - 346
Report from the ESMO 2019 Congress, Barcelona, September 27th – October 1st 2019 Congress Report ESMO 2019 28 November 2019 Pages: 65 - 82
HPV-associated cancers Christoph Minichsdorfer short review Open access 27 November 2019 Pages: 352 - 356
Surgery in renal cell carcinoma—when, whom and how? Sebastian LenartIngrid BergerAnton Ponholzer short review 21 November 2019 Pages: 347 - 351
First-line treatment of metastatic renal cell carcinoma: current standard of care Martin Marszalek short review 21 November 2019 Pages: 334 - 338
ASCO 2019—Personal highlights on adjuvant breast cancer: (neo-)adjuvant therapy of HER2-negative HR-positive BC Semir Beslija short review 21 November 2019 Pages: 305 - 307
Epidemiology of polycythemia vera in a Mexican population Antonio Olivas-MartinezOlga Barrales-BenítezElena Tuna-Aguilar original report 14 November 2019 Pages: 111 - 117
Second-line therapy in metastatic renal cell cancer—how do we treat after immuno-oncology drugs? Ursula Vogl short review 14 November 2019 Pages: 339 - 341
Management of nonmetastatic muscle invasive bladder cancer in the elderly Stephan Madersbacher short review 14 November 2019 Pages: 315 - 318
Role of CAR-T cell therapy in B-cell acute lymphoblastic leukemia Hildegard T. Greinix review Open access 14 November 2019 Pages: 36 - 42
ASCO 2019: highlights in HER2-positive metastatic breast cancer Rupert BartschElisabeth Bergen review Open access 12 November 2019 Pages: 308 - 311
